Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells

Biochemical Pharmacology

Volumn 53, Issue 2, 1997, Pages 207-214

  Abood, Mary E ^a,b   Ditto, Kara E ^a   Noel, Melissa A ^a   Showalter, Vincent M ^a   Qing, Tao ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cell line; DNA, recombinant; marijuana; mice; receptors; tetrahydrocannabinol

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; RECEPTOR SUBTYPE; RIMONABANT;

ANIMAL TISSUE; ARTICLE; BRAIN; GENE EXPRESSION; GENE TRANSFER; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SEQUENCE HOMOLOGY;

ANIMALS; BASE SEQUENCE; BINDING SITES; BRAIN; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; PIPERIDINES; PYRAZOLES; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0031028923     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00727-7     Document Type: Article

References (24)

1. Hollister LE, Health aspects of cannabis. Pharmacol Rev 38: 1-20, 1986.
2. Abood ME and Martin BR, Neurobiology of marijuana abuse. Trends Pharmacol Sci 13: 201-206, 1992.
3. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI, Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
4. Gerard CM, Mollereau C, Vassart G and Parmentier M, Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279: 129-134, 1991.
5. Felder CG, Veluz JS, Williams HL, Briley EM and Matsuda LA, Cannabinoid agonists stimulate both receptor-and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 42: 838-845, 1992.
6. Devane WA, Dysarz IFA, III, Johnson MR, Melvin LS and Hewlett AC, Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613, 1988.
7. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR and Martin BR, Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265: 218-226, 1993.
8. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrar P, Soubrie P, Breliere JC and Fur GL, SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244, 1994.
9. 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277: 586-594, 1996.
10. Dewey WL, Cannabinoid pharmacology. Pharmacol Rev 38: 151-178, 1986.
11. Chakrabarti A, Onaivi ES and Chaudhuri G, Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Sequence 5: 385-388, 1995.
12. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacol Biochem Behav 46: 575-579, 1993.
13. Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Fur GL, Caput D and Ferrara P, An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 270: 3726-3731, 1995.
14. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
15. Rosenthal HE, A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem 20: 525-537, 1967.
16. Scatchard G, The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51: 670-672, 1951.
17. Bramblett RD, Panu AM, Ballesteros JA and Reggio PH, Construction of a 3D model of the cannabinoid CB1 receptor: Determination of helix ends and helix orientation. Life Sci 56: 1971-1982, 1995.
18. Howlett AC, Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35: 607-634, 1995.
19. Howlett AC and Fleming RM, Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 26: 532-538, 1984.
20. Mackie K, Devane W and Hille B, Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44: 498-503, 1993.
21. Vogel Z, Barg J, Levy R, Saya D, Heldman E and Mechoulam R, Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61: 352-355, 1993.
22. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K and Devane WA, Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 90: 7656-7660, 1993.
23. Turkanis SA, Partlow LM and Karler R, Delta-9-tetrahydrocannabinol depresses inward sodium current in mouse neuroblastoma cells. Neuropharmacology 30: 73-77, 1991.
24. Lynn AB and Herkenham M, Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268: 1612-1623, 1994.